Qiao Y, Chen Z, Li W, Li H, Zhou L
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):10049-10059.
PMID: 38967825
DOI: 10.1007/s00210-024-03260-y.
Liu Y, Yuan S, Liu X, Huang Y, Qiu P, Gao J
J Mol Med (Berl). 2022; 100(9):1271-1286.
PMID: 35788718
DOI: 10.1007/s00109-022-02222-2.
Wang J, Lei C, Shi P, Teng H, Lu L, Guo H
Front Oncol. 2021; 11:714652.
PMID: 34497766
PMC: 8420713.
DOI: 10.3389/fonc.2021.714652.
Aydemir I, Turkoz Uluer E, Korkmaz O, Tuglu M, Inan S
Rom J Morphol Embryol. 2021; 61(3):707-714.
PMID: 33817712
PMC: 8112780.
DOI: 10.47162/RJME.61.3.09.
Wang H, Yang Q, Li J, Chen W, Jin X, Wang Y
Oncol Lett. 2021; 21(4):310.
PMID: 33732386
PMC: 7905532.
DOI: 10.3892/ol.2021.12570.
Decreased expression of miR-184 restrains the growth and invasion of endometrial carcinoma cells through CDC25A-dependent Notch signaling pathway.
Chen Z, Zhu Y, Fan X, Liu Y, Feng Q
Am J Transl Res. 2019; 11(2):755-764.
PMID: 30899377
PMC: 6413266.
Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.
Yan H, Sun B, Zhang Y, Li Y, Huang C, Feng F
Int J Mol Med. 2018; 42(5):2469-2480.
PMID: 30226564
PMC: 6192766.
DOI: 10.3892/ijmm.2018.3853.
Influence of Paclitaxel and Heparin on Vitality, Proliferation and Cytokine Production of Endometrial Cancer Cells.
Dinkic C, Kruse A, Zygmunt M, Schuetz F, Brucker J, Rom J
Geburtshilfe Frauenheilkd. 2017; 77(10):1104-1110.
PMID: 29093604
PMC: 5658230.
DOI: 10.1055/s-0043-119289.
PARP inhibition sensitizes endometrial cancer cells to paclitaxel-induced apoptosis.
Dinkic C, Jahn F, Zygmunt M, Schuetz F, Rom J, Sohn C
Oncol Lett. 2017; 13(4):2847-2851.
PMID: 28454476
PMC: 5403547.
DOI: 10.3892/ol.2017.5795.
Recent Advances in Endometrial Cancer.
Tran A, Gehrig P
F1000Res. 2017; 6:81.
PMID: 28184290
PMC: 5288678.
DOI: 10.12688/f1000research.10020.1.
The important application of thioridazine in the endometrial cancer.
Meng Q, Sun X, Wang J, Wang Y, Wang L
Am J Transl Res. 2016; 8(6):2767-75.
PMID: 27398159
PMC: 4931170.
Liver recurrence in endometrial cancer: a multi-institutional analysis of factors predictive of postrecurrence survival.
Toptas T, Karalok A, Ureyen I, Tasci T, Erol O, Bozkurt S
Clin Exp Metastasis. 2016; 33(7):707-15.
PMID: 27339214
DOI: 10.1007/s10585-016-9806-x.
MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S, Sun K, Liu B, Zong Z, Zhao Y
Mol Cancer. 2016; 15:11.
PMID: 26832151
PMC: 4736705.
DOI: 10.1186/s12943-016-0496-4.
Isolated abdominal wall metastasis of endometrial carcinoma.
Luz R, Leal R, Simoes J, Goncalves M, Matos I
Case Rep Obstet Gynecol. 2014; 2014:505403.
PMID: 25349753
PMC: 4198774.
DOI: 10.1155/2014/505403.
Fenretinide: a novel treatment for endometrial cancer.
Mittal N, Malpani S, Dyson M, Ono M, Coon J, Kim J
PLoS One. 2014; 9(10):e110410.
PMID: 25340777
PMC: 4207704.
DOI: 10.1371/journal.pone.0110410.
MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer Ishikawa cells.
Zhang G, Hou X, Li Y, Zhao M
BMC Cancer. 2014; 14:440.
PMID: 24929707
PMC: 4073515.
DOI: 10.1186/1471-2407-14-440.
MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN.
Li R, He J, Chen X, Long C, Yang D, Ding Y
Mol Biol Rep. 2014; 41(4):1977-84.
PMID: 24413994
DOI: 10.1007/s11033-014-3045-5.
Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts .
Guo F, Xun Q, Zhou H
Oncol Lett. 2013; 5(6):1777-1782.
PMID: 23833640
PMC: 3700935.
DOI: 10.3892/ol.2013.1295.
Phosphatase and tensin homolog (PTEN) pseudogene expression in endometrial cancer: a conserved regulatory mechanism important in tumorigenesis?.
Ioffe Y, Chiappinelli K, Mutch D, Zighelboim I, Goodfellow P
Gynecol Oncol. 2011; 124(2):340-6.
PMID: 22005521
PMC: 3954782.
DOI: 10.1016/j.ygyno.2011.10.011.
Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.
Dewdney S, Rimel B, Thaker P, Thompson Jr D, Schmidt A, Huettner P
Clin Cancer Res. 2011; 17(8):2120-9.
PMID: 21372219
PMC: 3242504.
DOI: 10.1158/1078-0432.CCR-10-2668.